Daewoong Pharma
KRX:069620
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Daewoong Pharma
KRX:069620
|
KR |
|
I
|
Information Services Group Inc
F:ZZG
|
US |
|
P
|
PPL Corp
SWB:PP9
|
US |
|
i-mobile Co Ltd
TSE:6535
|
JP |
|
B
|
Beijing Capital International Airport Co Ltd
SWB:BJ1
|
CN |
|
P
|
PPL Corp
F:PP9
|
US |
|
Wolters Kluwer NV
OTC:WOLTF
|
NL |
|
T
|
Tiong Woon Corporation Holding Ltd
SGX:BQM
|
SG |
|
E
|
Eisen und Huettenwerke AG
SWB:EIS
|
DE |
|
N
|
Nippon Yusen KK
OTC:NYUKF
|
JP |
|
S
|
Sun Hung Kai Properties Ltd
F:SHG
|
HK |
|
Bon-Ton Stores Inc
OTC:BONTQ
|
US |
|
M
|
Merck KGaA
DUS:MRK
|
DE |
|
Annaly Capital Management Inc
F:AAYA
|
US |
|
Burckhardt Compression Holding AG
F:B5H
|
CH |
|
L
|
Landstar System Inc
F:LDS
|
US |
Dividends
Dividend Yield
Daewoong Pharma
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Daewoong Pharma
Daewoong Pharma have decreased by 0%.
Payout Ratio
Daewoong Pharma
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Daewoong Pharma is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Daewoong Pharma
| Average Annual Return | -3.12% |
| Standard Deviation of Annual Returns | 30.8% |
| Max Drawdown | -52% |
| Market Capitalization | 1.2T KRW |
| Shares Outstanding | 11 590 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Daewoong Pharma's latest stock split occurred on Dec 27, 2012
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, Daewoong Pharma traded at 47199.9995 per share. Afterward, the share price was about 44228.2666.
The adjusted shares began trading on Dec 27, 2012. This was stock split number 6 in Daewoong Pharma's history, following the previous one in Dec 28, 2011.